MC-Gly-Gly-Phe-Gly is a pharmaceutical intermediate designed for use in antibody-drug conjugate manufacturing. It features multiple amide linkages and a maleimide group, providing a reactive handle for site-specific conjugation to antibodies.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2413428-36-9
(S)-10-Benzyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosan-1-oic acid
antibody-drug conjugate linker
MC-Gly-Gly-Phe
research reagent for conjugation
Mc-Gly-Gly-Phe-Gly-PAB-OH
research linker reagent
Monomethyl auristatin E
pharmaceutical intermediate for antibody-drug conjugate
N-Acetyl calicheamicin
pharmaceutical intermediate for antibody-drug conjugate
N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3,4-bis(dimethylamino)butanamide
Pharmaceutical reference impurity standard
1-(((2R,3S)-2-(2,5-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole
pharmaceutical intermediate
(alphaS,betaR)-beta-(2,5-Difluorophenyl)-beta-hydroxy-alpha-methyl-1H-1,2,4-triazole-1-butanenitrile
pharmaceutical intermediate
2-[[(2S)-2-[[2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetic acid
DWPLKZYCOGLRPC-SFHVURJKSA-N
C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)O)NC(=O)CNC(=O)CNC(=O)CCCCCN2C(=O)C=CC2=O